Live: Sensex\, Nifty Off Day’s Low; ICICI Bank Down 5%

Live: Sensex, Nifty Off Day’s Low; ICICI Bank Down 5%
People walk through a metal detector at a security check-point at the Bombay Stock Exchange (BSE) building in Mumbai, India. (Photographer: Kanishka Sonthalia/Bloomberg)  

Live: Sensex, Nifty Off Day’s Low; ICICI Bank Down 5%

Bookmark
Latest First
  • Oldest First

Buzzing Stock: BSE

  • Among the top performing stocks on the Nifty 500 index
  • Gains as much as 13.3% to Rs 558.7
  • Biggest single-day gain since February 2017
  • Trades at the highest level in five months
  • Snaps four-day losing streak
  • Today's volumes are 48% below its 20-day average
  • Has nearly doubled from its 52-week low of Rs 275 on March 24, 2020
  • All five analysts tracking the stocks have a buy recommendation
  • Return potential of the stock as per Bloomberg data is 13.2%

RBI Governor Interacts With Members Of The CII

Markets At Noon

  • Benchmark indices off day's low
  • Nifty down 0.4% at 11,147
  • Sensex down 0.4% at 37,977
  • Nifty Bank down 2.5% at 22,084
  • Nifty Midcap Index down 0.9%
  • Nifty Smallcap Index down 0.3%
  • India Volatility Index up 2.6% at 25.16
  • Nifty I.T. extends gains; up 1.6%
  • Nifty Metal is the other sectoral gainer; up 0.7%
  • Nifty PSU Bank, Nifty Realty down 2% each
  • Nifty Pharma is the other sectoral laggard; down 1.7%
  • BPCL is the top Nifty gainer; up 2.7%
  • ICICI Bank remains the top Nifty laggard; down 5.1%
  • 1,266 stocks on the NSE trade with losses; 512 gain

Stock Reaction: Alembic Pharma

The Board of Directors have approved an enabling resolution for an issuance of equity shares or NCDs along with warrants or any other combination thereof, for an amount not exceeding Rs 1,200 crore, the exchange filing said.

The board has also given its approval to raise capital up to Rs 1,000 crore through a Qualified Institutional Placement (QIP).

A fund raising committee will determine the issue size, schedule and discount (if applicable), according to the exchange filing.

Shares are off the day's low but trade with declines of 1% at Rs 971.

Earnings Reaction: Aarti Drugs

  • Revenue up 34% to Rs 544.7 crore
  • Net profit more than triples to Rs 85.45 crore
  • Ebitda up 2.5 times to Rs 134.1 crore
  • Ebitda margin at 24.6% from 13.5%
  • All numbers are consolidated and compared on a year-on-year basis

Shares gained as much as 14.1% - the most since April 2015 to trade at an all-time high of Rs 1,811. The stock is up for the fourth straight day.